On May 13, 2019, AEON Biopharma announced that Marc Forth, was elected to serve as President and CEO of the privately-held Newport Beach company. Marc was initiated with the Spring 1990 pledge class.

According to Cision PR Newswire, “ALPHAEON Corporation announced today that its Board of Directors has named Marc Forth as President and Chief Executive Officer of its newly established, wholly-owned subsidiary, AEON Biopharma, Inc. AEON Biopharma was established to independently pursue the rapidly growing, multi-billion-dollar, therapeutic toxin market. Therapeutic related applications represent greater than 60% of global neurotoxin segment revenues. Mr. Forth joins AEON Biopharma from Allergan, where he was Senior Vice President of Neurosciences, Urology and Medical Dermatology. Mr. Forth led, among other brands, BOTOX® Therapeutic, an organization with annual revenues of approximately $2 Billion.”

Sigma Chis throughout North America congratulate Marc on his success, and we all recognize that the White Cross of Sigma Chi has gained new luster by his life.